The Role of Fecal Calprotectin in Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth (SIBO)
Fecal calprotectin (FC) is a quick, cost-effective, and noninvasive test, which is used to diagnose patients with active inflammatory bowel diseases (IBD). Recent studies suggest the possible predictive role of FC in the diagnosis of small intestinal bacterial overgrowth (SIBO) in patients with syst...
Main Authors: | Beata Polkowska-Pruszyńska, Agnieszka Gerkowicz, Karol Rawicz-Pruszyński, Dorota Krasowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/8/587 |
Similar Items
-
Small Intestinal Bacterial Overgrowth (SIBO): Result of Altered Defensive Mechanism in Gastrointestinal – A Review
by: Alvin Hartanto Kurniawan, et al.
Published: (2020-07-01) -
SIBO in pediatric population: literature review on pathogenesis, symptoms, diagnosis and treatment
by: Martyna Opatowska, et al.
Published: (2024-07-01) -
Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases—Current State of Knowledge
by: Paulina Roszkowska, et al.
Published: (2024-05-01) -
Small Intestinal Bacterial Overgrowth Syndrome: New Clinical Insights for Multimorbid and High-Risk Patients
by: Krzysztof Nowakowski, et al.
Published: (2024-12-01) -
Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)
by: Huaizhu Guo, et al.
Published: (2023-02-01)